Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (34472)	5/9/2007 10:56:44 AM
From: wyllisx2	Respond to of 48461

sold out my position in SIGA at 4.00, been a sweet ride & the first loss taken in SIGA ever. I'm looking to rebuy in a few days at 3.00-3.25 area. Of course I'll be wrong & it'll jump 15.00 tomorrow, kind of like MDII did the last time.

To: Bucky Katt who wrote (34472)	5/9/2007 11:24:54 AM
From: joseffy	Respond to of 48461

The worst case I know of was a Chinese guy I knew who sold his restaurant and property (huge parking lot around it) after many decades in the business. He put EVERYTHING he had from the restaurant sale into a single stock--a China related stock, which had already moved from 3 to over 100. When I discussed, gently, with him that maybe it wasn't good to put everything in one stock, he extolled the virtues of the company. When I said that maybe it was the wrong timeliness to buy a stock after it had already moved from 3 to over 100, he said he was loyal to his original country and I wouldn't be able to understand that. Then it started down. After I noticed it was down about 40%, I said of course he must gotten out and saved the majority of his money. He said, no, he hadn't sold a share, and was WAITING FOR IT TO GO BACK UP. And it continued down. So now, instead of living in retirement, he got himself trained in computer technology and now drives a total of over two and half hours a day to a low paying job handling simple customer problems over the phone at a computer company. His wife left him. But he was loyal to his stock.

To: Bucky Katt who wrote (34472)	5/9/2007 12:37:30 PM
From: joseffy	Read Replies (1) \| Respond to of 48461

Here is a beauty of an example of "all in" thinking. It was just posted by a devout DNDN holder in reaction to today's plunge: ............................................................ a pox on them all ... The value of my portfolio just took a major hit (more ‘major’ than any hit it has taken over my twenty-five years of investing). Since I intend to hang onto every one of my shares of DNDN, the hit is just on paper, but it represents a psychological hit nonetheless. My opinion of the presence of integrity in our government-appointed institutions (a growing oxymoron, if there ever was one) has taken an exponentially larger hit than has my portolio. As I see it, today’s announcement simply boils down to the fact that, whether directly or indirectly, von Eschenbach and his FDA was successfully pressured to await further proof of the efficacy of Provenge, because the making (or, in this case) preserving of the almighty dollar by a powerful class of investing elite has been deemed to be of more importance than (1) the timely providing of relief from pain and impending death to current sufferers of advanced prostate cancer, and (2) (less important, but important nonetheless) fairness in the world’s financial markets. As a result of this bogus need for more information, not only will the manufacture of a ground-breaking, revolutionary treatment for cancer be delayed (I am frothing at the mouth as I type this), but those powerful people in the ‘investing’ (and I use the term loosely) community who had bet against the success of this therapy we be able to avoid major, catastrophic dollar losses, while, at the same time, preventing honest retail investors from realizing the gains they would have realized, had a short squeeze been allowed to naturally occur. In addition to the above gross injustices, future biotech research and development may also be dramatically negatively affected by this decision, should final approval be delayed more than a few months. The larger and more rigorous the number of hoops required in order to apply for financing, or eventually get the go ahead, to proceed with early phase trials of new and innovative science for the treatment of major diseases, the less likely smaller companies will be to take on the risk. ‘Right’ took a major blow today. But, call me naïve if you must, I still firmly believe in this company, its product(s), and the benefits they will eventually offer the suffering of our country and our world. It is simply an abomination that (1) elite financial power brokers now appear to enjoy the final word in decisions in which human life and human dignity are at stake, and that (2) those same elite financial power brokers can have their investing mistakes declared null and void by simply applying pressure to the government agency in whose hands life-and-death decisions rest. The only choice we legitimate private investors have to make now, is do we hold fast to our belief in this company and its product, assuming that, once the big guys who had bet against us have taken the necessary steps to curtail or erase their losses, approval will be granted? I, for one, am holding – simply because I will not remove my support from a company and product in which I believe. But it chills me to the bone to know that an agency of my government has allowed the powerful non-believers to have their way – at my expense, and at the expense of the present and future sick and dying. A pox on the SEC, the FDA, and those who place the amassing of the almighty dollar above the sanctity and dignity of human life. Best to all prostate cancer patients, and all who intend to remain faithful to pure and genuine science aimed at alleviating human suffering. investorvillage.com